Perspective Therapeutics, Inc. (CATX)
3.76
-0.09
(-2.34%)
USD |
NYAM |
May 18, 16:00
3.78
+0.02
(+0.53%)
After-Hours: 20:00
Perspective Therapeutics Research and Development Expense (Quarterly) : 20.25M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.865M |
| AVITA Medical, Inc. | 5.629M |
| Twist Bioscience Corp. | 19.70M |
| Elutia, Inc. | 1.973M |
| TriSalus Life Sciences, Inc. | 3.216M |